The latest information that came from Cellceutix Corp (OTCMKTS:CTIX)‘s front is the selection of independent directors and committee members. On Monday, the clinical state bio-pharma company disclosed that it has welcomed Dr. Barry Alan Schechter, Dr. Zorik Spektor and Mark Tobin on its board of independent directors and committee members.

New members on board

The company provided a brief account of the background of all the newly appointed independent directors in its note. It said that Dr. Schechter is currently serving at Florida Eye Microsurgical Institute as Director of Department of Cornea and External Disease. He has been affiliated with the Institute since 2005. Cellceutix Corp (OTCMKTS:CTIX) also noted that Dr. Schechter had co-founded Pediavision, which was established to save children’s eyesight. Pediavision has recently been sold, the press release noted.

Dr. Spektor, M.D., F.A.A.P. is a Head and Neck Surgeon and is also a Pediatric Otolaryngologist, according to the company furnished press release. Dr. Spektor has been serving The Center for Pediatric ENT – Head and Neck Surgery since 1995, the company briefed. Moving on to Mr. Tobin, Cellceutix Corp (OTCMKTS:CTIX) informed that he is currently Director at Digital Offering, where he heads the Research department. Mr. Tobin has been working with the merchant bank since October 2013 while he is also a Managing Partner at Tobin Tao & Company.

Additional information

Other than introducing the new faces on the Board, Cellceutix Corp (OTCMKTS:CTIX) also added that its presentations delivered at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) during April 25-April 28, 2015 at Copenhagen, Denmark will be made available on its website. The company had recently provided an update on its primary drug candidate ‘Briladicin’. The stock of Cellceutix Corp (OTCMKTS:CTIX) settled 1.72% higher at $2.95 as 206,000 shares changed hands during the previous trading session.

Previous articleNet Savings Link Inc (OTCMKTS:NSAV) Closes Acquisition of Pyrotree Inc.
Next articleAmerican Green Inc (OTCMKTS:ERBB) Gains As More Americans Want Marijuana Legalization
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.